Listen, Dream, and Change: Using the Power of Patients to Improve Care
15/01/2013There’s Value in Studying Big Pharma Pipelines – Forbes
15/01/2013Patients laud Lundbeck, Gilead, but give pharma’s rep low marks – FiercePharma
According to the annual PatientView survey, 42% of patient groups in 56 countries rated pharma’s reputation as « fair, » while 25% called the industry’s rep « poor. » (Patients laud #Lundbeck, #Gilead, but give pharma’s rep low marks: Approval ratings…
See on www.fiercepharma.com
